In parallel, IHC analysis of the tumour sections confirmed HER2 expression of the tumours by a 2+ HER2 DAKO score for expression which was homogenously distributed throughout the tumour section, while CAIX expression was confined to the peri-necrotic tumour areas (Fig. 6d). The gene discussed is ERBB2; the disease is neoplasm.